Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025

Core Insights - Compass Pathways plc is set to announce its third quarter financial results for the period ending September 30, 2025, on November 4, 2025, and will provide updates on recent developments [1][2] Company Overview - Compass Pathways is a biotechnology company focused on improving patient access to evidence-based innovations in mental health, particularly for those with serious mental health conditions unresponsive to existing treatments [3][4] - The company is developing COMP360, a synthesized psilocybin treatment, which has received Breakthrough Therapy designation from the FDA and Innovative Licensing and Access Pathway designation in the UK for treatment-resistant depression [3] Upcoming Events - Management will host a conference call on November 4, 2025, at 8:00 am ET (1:00 pm UK), with a live webcast available on the company's website [2] - Compass Pathways is participating in several investor conferences, including the Cantor Global Healthcare Conference and the Morgan Stanley 23rd Annual Global Healthcare Conference in September 2025 [8][9]